Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Road NE
Atlanta, GA 30322Phone+1 404-778-2386- Is this information wrong?
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
- Ohio State University HospitalResidency, Internal Medicine, 2007 - 2010
- University of Florida College of MedicineClass of 2007
Certifications & Licensure
- GA State Medical License 2013 - 2024
- OH State Medical License 2007 - 2015
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
- Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2016 Jan 01
- Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission Start of enrollment: 2016 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, ...> ;Cancers. 2023 Feb 24
- Postibrutinib relapse outcomes for patients with marginal zone lymphoma.Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K Moyo, Nishitha Reddy, Julia Sheets, David M Weiner, Praveen Ramakrishnan Geethakumar...> ;Blood Advances. 2023 Jan 10
- 1 citationsAntibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.Andres Chang, Akil Akhtar, Lilin Lai, Victor M Orellana-Noia, Susanne L Linderman, Ashley A McCook-Veal, Jeffrey M Switchenko, Manpreet Saini, Rajesh M Valanparambil, ...> ;Cancer Research Communications. 2022 Dec 1
- Join now to see all
Journal Articles
- Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-cell Lymphoma at an Academic Healthcare SystemJonathon Cohen, MD, Clinical Lymphoma, Myeloma, & Leukemia
Abstracts/Posters
- Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Multi-Institution Phase I/Ib Continual Re-Assessment Study to Identify the Optimal Dose of of Ibrutinib (IBR) and Venetoclax (VEN) in Relapsed or Refractory Mantle Cel...Jonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective AnalysisJonathon B. Cohen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Expert Perspectives on the Role of BTK Inhibitors in CLL61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Phase I/II Study of Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: PrE040461st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Authored Content
- ASH 2018: Novel Therapies for Relapsed/Refractory Aggressive LymphomasDecember 2018
- ASH 2018: Novel Therapies for Relapsed/Refractory Aggressive LymphomasDecember 2018
Press Mentions
- Expert Discusses Treatment with BV+AVD Regimen in a Classic Hodgkin Lymphoma Case StudyMay 3rd, 2019
- Nivolumab for Newly Diagnosed AdvancedApril 8th, 2019
- Deferred Therapy Safe, Effective in Some Mantle Cell Lymphoma PatientsMay 11th, 2016
- Join now to see all
Hospital Affiliations
- Emory University HospitalAtlanta, Georgia
- Emory University Hospital MidtownAtlanta, Georgia
- Emory Saint Joseph's Hospital of AtlantaAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: